The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Cell-cycle checkpoints and cancer
Abstract
All life on earth must cope with constant exposure to DNA-damaging agents such as the Sun's radiation. Highly conserved DNA-repair and cell-cycle checkpoint pathways allow cells to deal with both endogenous and exogenous sources of DNA damage. How much an individual is exposed to these agents and how their cells respond to DNA damage are critical determinants of whether that individual will develop cancer. These cellular responses are also important for determining toxicities and responses to current cancer therapies, most of which target the DNA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CHK1 prevents new origin firing by inhibiting CDK2 through CDC25A degradation, thus hindering the subsequent loading of CDC45 on chromatin to form the pre-initiation complex [34].”
From The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia (2017) · cites this paper as [34]
In the citing paper
“The importance of the DNA damage checkpoint in the maintenance of genomic stability is underlined by the existence of many syndromes linked to mutations in checkpoint genes, causing increased cancer proneness or other clinical symptoms, especially neurological defects [13,14]”
From Mind the gap: keeping UV lesions in check (2011) · cites this paper as [13]
In the citing paper
“while p53-mutant mice are cancer prone, we noted that their predilection for mesenchymal and lymphoid malignancies, rather than epithelial cancers, did not represent the tumor types most commonly possessing p53 mutations in humans (101,102).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [101]
In the citing paper
“factors involved in DNA repair and DDR pathways have become therapeutic targets and are currently being tested in both laboratory and clinical studies [151, 222]”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [222]
Citations
Cites
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Doll, R., & Peto, R. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1192 · Cited by 3,927
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Peto, R. (1983) · Springer eBooks · doi:10.1007/978-1-4757-1117-2_30 · Cited by 3,504
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Self-citationCheckpoints: Controls That Ensure the Order of Cell Cycle Events
Hartwell, L. H., & Weinert, T. A. (1989) · Science · doi:10.1126/science.2683079 · Cited by 3,053
Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
Zou, L., & Elledge, S. J. (2003) · Science · doi:10.1126/science.1083430 · Cited by 2,693
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Megabase Chromatin Domains Involved in DNA Double-Strand Breaks in Vivo
Rogakou, E. P., Boon, C., Redon, C., & Bonner, W. M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.905 · Cited by 2,422
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713
Research works printed but not linked: 1
- Ford, J. M. Clinical Oncology (eds Abeloff, M. et al.) Ch. 11, 191–205 (Elsevier, Philadelphia, 2004).
Cited by
Sorted by citations
Items 801–900 of 1,008
Hypoxia Enhances the Radioresistance of Mouse Mesenchymal Stromal Cells
Sugrue, T., Lowndes, N. F., & Ceredig, R. (2014) · Stem Cells · doi:10.1002/stem.1683 · Cited by 49
Bártek, J. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.07.006 · Cited by 47
Androgen Receptor Signaling Fuels DNA Repair and Radioresistance in Prostate Cancer
Bártek, J., Mistrík, M., & Bártková, J. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0679 · Cited by 47
Barsanti, P. A., Aversa, R. J., Jin, X., Pan, Y., Lu, Y., Elling, R. A., Jain, R., Knapp, M. S., Lan, J., Lin, X., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500353p · Cited by 47
Fischler, T., Li, Y., Wang, R.-H., Kim, H.-S., Sengupta, K., Vassilopoulos, A., Lahusen, T. J., Xu, X., Lee, M.-H., Liu, Q., et al. (2010) · Oncogene · doi:10.1038/onc.2010.163 · Cited by 47
Mori, T., Ikeda, D. D., Yamaguchi, Y., & Unoki, M. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.038 · Cited by 50
p53 Prevents Entry into Mitosis with Uncapped Telomeres
Thanasoula, M., Escandell, J. M., Martínez, P., Badie, S., Muñoz, P., Blasco, M. A., & Tarsounas, M. (2010) · Current Biology · doi:10.1016/j.cub.2010.01.046 · Cited by 49
Rieck, S., Zhang, J., Li, Z., Liu, C., Naji, A., Takane, K. K., Fiaschi‐Taesch, N., Stewart, A. F., Kushner, J. A., & Kaestner, K. H. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1019 · Cited by 49
Yoshida, K., Sugimoto, N., Iwahori, S., Yugawa, T., Narisawa‐Saito, M., Kiyono, T., & Fujita, M. (2010) · Journal of Cell Science · doi:10.1242/jcs.058693 · Cited by 48
Chayapong, J., Madhyastha, H., Madhyastha, R., Nurrahmah, Q. I., Nakajima, Y., Choijookhuu, N., Hishikawa, Y., & Maruyama, M. (2016) · Environmental Science and Pollution Research · doi:10.1007/s11356-016-8215-7 · Cited by 47
Terzuoli, E., Nannelli, G., Frosini, M., Giachetti, A., Ziche, M., & Donnini, S. (2017) · Oncotarget · doi:10.18632/oncotarget.20544 · Cited by 47
Lee, K.-J., Ahn, J., Lee, K., Jang, D. S., & Choi, J. (2018) · Nutrients · doi:10.3390/nu10010091 · Cited by 47
Cell-Cycle–Dependent Phosphorylation of PRPS1 Fuels Nucleotide Synthesis and Promotes Tumorigenesis
Jing, X., Wang, X.-J., Zhang, T., Zhu, W., Fang, Y., Wu, H., Liu, X., Ma, D., Ji, X., Jiang, Y., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2486 · Cited by 47
Zhu, F., Dai, S., Xu, D., Hou, C., Liu, T., Chen, Q.-Y., Wu, J., & Miao, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109972 · Cited by 47
Mognato, M., Girardi, C., Fabris, S., & Celotti, L. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.01.002 · Cited by 50
Merolla, F., Luise, C., Muller, M. T., Pacelli, R., Fusco, A., & Celetti, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036177 · Cited by 48
RetractedATM Limits Incorrect End Utilization during Non-Homologous End Joining of Multiple Chromosome Breaks
Bennardo, N., & Stark, J. M. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001194 · Cited by 48
Chopra, A. S., Anderson, A. L., & Giardina, C. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.499319 · Cited by 46
Ma, X., Hui, H., Jin, Y., Dong, D., Liang, X., Yang, X., Tan, K., Dai, Z., Cheng, Z., & Tian, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.007 · Cited by 46
Ciliogenesis and the DNA damage response: a stressful relationship
Johnson, C. A., & Collis, S. J. (2016) · Cilia · doi:10.1186/s13630-016-0040-6 · Cited by 49
Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells
Zhou, X., Liu, W., Hu, X., Dorrance, A. M., Garzon, R., Houghton, P. J., & Shen, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-01729-w · Cited by 46
Maheswari, U., Ghosh, K. K., & Sadras, S. R. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1449-8 · Cited by 46
Stukenberg, P. T., & Burke, D. J. (2015) · Chromosoma · doi:10.1007/s00412-015-0515-z · Cited by 47
Turesson, I., Nyman, J., Qvarnström, F., Simonsson, M., Book, M., Hermansson, I., Sigurðardóttir, S., & Johansson, K.-A. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.10.007 · Cited by 47
Pei, X., Dai, Y., Youssefian, L. E., Chen, S., Bodie, W. W., Takabatake, Y., Felthousen, J. G., Almenara, J. A., Kramer, L. B., Dent, P., et al. (2011) · Blood · doi:10.1182/blood-2011-02-339432 · Cited by 46
Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition
Flatmark, K., Nome, R. V., Folkvord, S., Bratland, Å., Rasmussen, H., Ellefsen, M. S., Fodstad, Ø., & Ree, A. H. (2006) · Radiation Oncology · doi:10.1186/1748-717x-1-25 · Cited by 49
Obe, G., & Vijayalaxmi, V. (2007) · Springer eBooks · doi:10.1007/978-3-540-71414-9 · Cited by 46
DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers
Kotsopoulos, J., Chen, Z., Vallis, K. A., Poll, A., Ainsworth, P., & Narod, S. A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603528 · Cited by 46
Cleavage of Claspin by Caspase-7 during Apoptosis Inhibits the Chk1 Pathway
Clarke, C., Bennett, L. N., & Clarke, P. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506460200 · Cited by 46
Bhatt, P., Khatri, N., Kumar, M., Baradia, D., & Misra, A. R. (2014) · Drug Delivery · doi:10.3109/10717544.2014.898348 · Cited by 49
Carvacrol as a Prospective Regulator of Cancer Targets/Signalling Pathways
Singh, J., Luqman, S., & Meena, A. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220705142954 · Cited by 50
Synchronisation and control of proliferation in cycling cell population models with age structure
Billy, F., Clairambault, J., Fercoq, O., Gaubertt, S., Lepoutre, T., Ouillon, T., & Saito, S. (2012) · Mathematics and Computers in Simulation · doi:10.1016/j.matcom.2012.03.005 · Cited by 45
Oct4 Interaction with Hmgb2 Regulates Akt Signaling and Pluripotency
Campbell, P. A., & Rudnicki, M. A. (2013) · Stem Cells · doi:10.1002/stem.1365 · Cited by 46
Weidner, C., Rousseau, M., Micikas, R. J., Fischer, C., Plauth, A., Wowro, S. J., Siems, K., Hetterling, G., Kliem, M., Schroeder, F. C., et al. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00072 · Cited by 45
Long, N. P., Jung, K. H., Yoon, S. J., Anh, N. H., Nghi, T. D., Kang, Y. P., YAN, H. H., Min, J. E., Hong, S., & Kwon, S. W. (2017) · Oncotarget · doi:10.18632/oncotarget.22689 · Cited by 46
BAHMAN, A.-M., Abaza, M. S. I., Khoushiash, S., & Al‐Attiyah, R. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3725 · Cited by 45
Qin, Q., Wang, S., Tan, M., Wang, Z., Huang, X., Wei, Q.-M., Shi, B.-B., Zou, B., & Liang, H. (2018) · Metallomics · doi:10.1039/c8mt00125a · Cited by 45
Burgess, B. T., Anderson, A. M., McCorkle, J. R., Wu, J., Ueland, F. R., & Kolesar, J. (2020) · Diagnostics · doi:10.3390/diagnostics10020121 · Cited by 46
Guo, Y., Zhang, X., Yang, M., Miao, X., Shi, Y., Yao, J., Tan, W., Sun, T., Zhao, D., Yu, D., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.074252 · Cited by 47
Analysis of variants in DNA damage signalling genes in bladder cancer
Choudhury, A., Elliott, F., Iles, M. M., Churchman, M., Bristow, R. G., Bishop, D. T., & Kiltie, A. E. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-69 · Cited by 45
The regulation of radiosensitivity by p53 and its acetylation
Zhang, J., Shen, L., & Sun, L. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.015 · Cited by 45
DNA damage signaling is activated during cancer progression in human colorectal carcinoma
Kazuhito, O. K. A., Tanaka, T., Enoki, T., Yoshimura, K., Ohshima, M., Kubo, M., Murakami, T., Gondou, T., Minami, Y., Takemoto, Y., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.3.10751 · Cited by 45
DNA Repair Deficiency and Neurodegeneration
Katyal, S., & McKinnon, P. J. (2007) · Cell Cycle · doi:10.4161/cc.6.19.4757 · Cited by 46
Nodin, B., Zendehrokh, N., Sundström, M., & Jirström, K. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-106 · Cited by 45
Oxidative stress-induced DNA damage and cell cycle regulation in B65 dopaminergic cell line
Pizarro, J. G., Folch, J., de la Torre, A. V., Verdaguer, E., Junyent, F., Jordán, J., Pallàs, M., & Camins, A. (2009) · Free Radical Research · doi:10.1080/10715760903159188 · Cited by 45
Viral-induced human carcinogenesis: an oxidative stress perspective
Georgakilas, A. G., Mosley, W. G., Georgakila, S., Ziech, D., & Panayiotidis, M. I. (2010) · Molecular BioSystems · doi:10.1039/b923958h · Cited by 46
Cao, F., Zhou, T., Simpson, D. A., Zhou, Y., Boyer, J. C., Chen, B., Jin, T., Cordeiro‐Stone, M., & Kaufmann, W. K. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.10.031 · Cited by 45
Zhao, L., Jin, F. J., Ye, X., Zhu, L., Yang, J., & Yang, W. (2015) · Biochemical Journal · doi:10.1042/bj20150116 · Cited by 44
Morandell, S., & Yaffe, M. B. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-387665-2.00011-0 · Cited by 45
Valenti, F., Ganci, F., Fontemaggi, G., Sacconi, A., Strano, S., Blandino, G., & Agostino, S. D. (2015) · Oncotarget · doi:10.18632/oncotarget.2587 · Cited by 45
Oka, Y., Suzuki, K., Yamauchi, M., Mitsutake, N., & Yamashita, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.021 · Cited by 44
Proteolysis of Rad17 by Cdh1/APC regulates checkpoint termination and recovery from genotoxic stress
Zhang, L., Park, C.-H., Wu, J., Kim, H., Liu, W., Fujita, T., Balasubramani, M., Schreiber, E. M., Wang, X.-F., & Wan, Y. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.55 · Cited by 44
Chk1 and Wee1 control genotoxic-stress induced G2–M arrest in melanoma cells
Vera, J., Raatz, Y., Wolkenhauer, O., Kottek, T., Bhattacharya, A., Simon, J. C., & Kunz, M. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.01.020 · Cited by 44
Lee, H. E., Han, N., Kim, M. A., Lee, H. S., Yang, H., Lee, B. L., & Kim, W. H. (2013) · Pathobiology · doi:10.1159/000351072 · Cited by 44
Lack of Bcl11b tumor suppressor results in vulnerability to DNA replication stress and damages
Kamimura, K., Mishima, Y., Obata, M., Endo, T., Aoyagi, Y., & Kominami, R. (2007) · Oncogene · doi:10.1038/sj.onc.1210388 · Cited by 45
Chen, X., Wong, P. W., Radany, E. H., Stark, J. M., Laulier, C., & Wong, J. Y. C. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0587 · Cited by 44
DNA Damage-Induced Cell Cycle Regulation and Function of Novel Chk2 Phosphoresidues
Buscemi, G., Carlessi, L., Zannini, L., Lisanti, S., Fontanella, E., Canevari, S., & Delia, D. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00534-06 · Cited by 45
Specian, A. F. L., Serpeloni, J. M., Tuttis, K., Ribeiro, D. L., Cilião, H. L., Varanda, E. A., Sannomiya, M., Martínez-López, W., Vilegas, W., & Cólus, I. M. D. S. (2016) · Cytotechnology · doi:10.1007/s10616-016-9998-6 · Cited by 44
Lee, B. L., Singh, A., Glover, J. N. M., Hendzel, M. J., & Spyracopoulos, L. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.05.029 · Cited by 48
Khan, N. S., Κhan, P., Ansari, M. F., Srivastava, S., Hasan, G. M., Husain, M., & Hassan, M. I. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00566 · Cited by 44
A circular RNA hsa_circ_0079929 inhibits tumor growth in hepatocellular carcinoma
Zheng, H. S., Chen, T., Li, C., Xu, C., Ding, C., Chen, J., Ju, S., Zhang, Z., Liang, Z., Cui, Z., et al. (2019) · Cancer Management and Research · doi:10.2147/cmar.s189338 · Cited by 44
Haneef, J., Parvathy, M., Santhosh Kumar Thankayyan, R., Sithul, H., & Sreeja, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040055 · Cited by 44
Regenbrecht, C. R. A., Jung, M., Lehrach, H., & Adjaye, J. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-49 · Cited by 44
Chang, B. H., Smith, L. G., Huang, J., & Thayer, M. J. (2006) · Oncogene · doi:10.1038/sj.onc.1209995 · Cited by 44
Mind the gap: keeping UV lesions in check
Novarina, D., Amara, F., Lazzaro, F., Plevani, P., & Muzi-Falconi, M. (2011) · DNA Repair · doi:10.1016/j.dnarep.2011.04.030 · Cited by 43
“c c d p ially neurological defects [13,14]; it is thus not surprising that hese pathways are extremely conserved throughout evolution Table 1).”
BackgroundNCAPG Is a Promising Therapeutic Target Across Different Tumor Types
Xiao, C., Gong, J., Jie, Y., Cao, J., Chen, Z., Li, R., Chong, Y., Hu, B., & Zhang, Q. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00387 · Cited by 44
Yang, G., Yang, X., Lu, H., Ren, Y., Ma, M.-Z., Zhu, L.-Y., Wang, J.-H., Song, W., Zhang, W., Zhang, R., et al. (2014) · Europe PMC (PubMed Central) · Cited by 43
Ma, H., Rao, L., Wang, H. L., Mao, Z. W., Lei, R., Yang, Z., Qing, H., & Deng, Y. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.412 · Cited by 43
Anticancer effects of crocetin in human esophageal squamous cell carcinoma KYSE-150 cells
Li, S., Jiang, S., Jiang, W., Zhou, Y., Shen, X., Luo, T., Ling-ping, K., & WANG, H.-Q. (2015) · Oncology Letters · doi:10.3892/ol.2015.2869 · Cited by 43
Du, L., Borkowski, R. J., Zhao, Z., Ma, X., Yu, X., Xie, X., & Pertsemlidis, A. (2013) · RNA Biology · doi:10.4161/rna.26541 · Cited by 43
Requirement of MTA1 in ATR-mediated DNA Damage Checkpoint Function
Li, D., Ohshiro, K., Khan, M. N., & Kumar, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085258 · Cited by 44
Take your PIKK: tumour viruses and DNA damage response pathways
Pancholi, N. J., Price, A. M., & Weitzman, M. D. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0269 · Cited by 44
Yu, C.-Y., Teng, C. J., Hung, P.-S., Cheng, C., Hsu, S., Hwang, G., & Tzeng, Y. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.09.050 · Cited by 43
Kim, M., Jee, S.-C., Sung, J., & Kadam, A. A. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.06.074 · Cited by 43
Sachan, R., Kundu, A. B., Jeon, Y., Choi, W. S., Yoon, K., Kim, I. S., Kwak, J. H., & Kim, H. S. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.10.012 · Cited by 43
Qin, Q., Zou, B., Wang, Z., Huang, X., Zhang, Y., Tan, M., Wang, S., & Liang, H. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111727 · Cited by 43
Fucoidan Inhibition of Osteosarcoma Cells is Species and Molecular Weight Dependent
Gupta, D., Silva, M., Radziun, K., Martinez, D. C., Hill, C. J., Marshall, J., Hearnden, V. L., Puertas-Mejía, M. A., & Reilly, G. C. (2020) · Marine Drugs · doi:10.3390/md18020104 · Cited by 46
Potential pathways of zinc deficiency-promoted tumorigenesis
Zhang, Y., Tian, Y., Zhang, H., Xu, B., & Chen, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110983 · Cited by 43
Cell Cycle Stage Classification Using Phase Imaging with Computational Specificity
He, Y. R., He, S., Kandel, M. E., Lee, Y. J., Hu, C., Sobh, N., Anastasio, M. A., & Popescu, G. (2022) · ACS Photonics · doi:10.1021/acsphotonics.1c01779 · Cited by 43
Wang, Z., Zhou, X.-F., Wei, Q.-C., Qin, Q., Li, J., Tan, M., & Zhang, S. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114418 · Cited by 43
Dual Regulation of Cdc25A by Chk1 and p53-ATF3 in DNA Replication Checkpoint Control
Demidova, A. R., Aau, M. Y., Li, Z., & Yu, Q. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808118200 · Cited by 43
IKKα Regulates the Mitotic Phase of the Cell Cycle by Modulating Aurora A Phosphorylation
Prajapati, S., Yamamoto, Y., Gaynor, R. B., & Tu, Z. (2006) · Cell Cycle · doi:10.4161/cc.5.20.3359 · Cited by 43
Cooperative Role of the RNA-Binding Proteins Hzf and HuR in p53 Activation
Nakamura, H., Kawagishi, H., Watanabe, A., Sugimoto, K., Maruyama, M., & Sugimoto, M. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01424-10 · Cited by 45
Adiga, S. K., Toyoshima, M., Shimura, T., Takeda, J., Uematsu, N., & Niwa, O. (2007) · Reproduction · doi:10.1530/rep-06-0048 · Cited by 43
Wong, P. Y., Ma, H. T., Lee, H., & Poon, R. Y. C. (2016) · Scientific Reports · doi:10.1038/srep22230 · Cited by 43
Baranski, Z., Booij, T. H., Cleton-Jansen, A., Price, L., van de Water, B., Bovée, J. V. M. G., Hogendoorn, P. C. W., & Danen, E. H. J. (2015) · The Journal of Pathology · doi:10.1002/path.4528 · Cited by 42
HCLK2 Is Required for Activity of the DNA Damage Response Kinase ATR
Danielsen, J. M. R., Larsen, D. H., Schou, K. B., Freire, R., Falck, J., Bártek, J., & Lukas, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808174200 · Cited by 43
Drissi, R., Wu, J., Hu, Y., Bockhold, C. A., & Dome, J. S. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0069 · Cited by 42
CDDO-Imidazolide Induces DNA Damage, G2/M Arrest and Apoptosis in BRCA1-Mutated Breast Cancer Cells
Kim, E., Deng, C., Sporn, M. B., & Liby, K. T. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0153 · Cited by 42
Rossi, R., Lidonnici, M. R., Soza, S., Biamonti, G., & Montecucco, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2741 · Cited by 42
Min, J., Guo, K., Suryadevara, P. K., Zhu, F., Holbrook, G., Chen, Y., Féau, C., Young, B. M., Lemoff, A. S., Connelly, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01092 · Cited by 42
Self-citationMAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors
Rossi, M., Colecchia, D., Ilardi, G., Acunzo, M., Nigita, G., Sasdelli, F., Celetti, A., Strambi, A., Staibano, S., Croce, C. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8044 · Cited by 42
Fási, L., Meo, F. D., Kuo, C., Burić, S. S., Martins, A., Kúsz, N., Béni, Z., Dékány, M., Balogh, G. T., Pešić, M., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01994 · Cited by 42
Cheng, Y., Lin, T.-Y., & Shieh, S.-Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220635110 · Cited by 42
Ganzinelli, M., Carrassa, L., Crippa, F., Tavecchio, M., Broggini, M., & Damia, G. L. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0304 · Cited by 42
Kim, S., Nam, K., Hwang, K., & Choi, K. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.01.008 · Cited by 42
Polo-like kinases and DNA damage checkpoint: beyond the traditional mitotic functions
Bahassi, E. M. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011011 · Cited by 42
Chen, X., Wang, Z., Zhu, Y., Zhang, C., Liu, M., Hu, X., Chen, W., & Du, Y. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.53243 · Cited by 41
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL
Zhao, Y., Short, N. J., Kantarjian, H. M., Chang, T.-C., Ghate, P. S., Qu, C., Macaron, W., Jain, N., Thakral, B., Phillips, A. H., et al. (2024) · Blood · doi:10.1182/blood.2024023930 · Cited by 41
Purine Bases Oxidation and Repair Following Permethrin Insecticide Treatment in Rat Heart Cells
Vadhana, M. S. D., Nasuti, C., & Gabbianelli, R. (2010) · Cardiovascular Toxicology · doi:10.1007/s12012-010-9079-6 · Cited by 41
Metadata
- Authors
- Kastan, M. B., & Bartek, J.
- Affiliations
- St. Jude Children's Research Hospital (US)
- ORCID
- Kastan, Michael B.
- Venue
- Nature
- Published
- 2004-11
- Volume
- 432
- Issue
- 7015
- Pages
- 316-323
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1965239527
- Cited by
- 2,836
- References
- 98
- Citations by year
- 2026: 61 · 2025: 71 · 2024: 70 · 2023: 111 · 2022: 132 · 2021: 151 · 2020: 144 · 2019: 119 · 2018: 114 · 2017: 130 · 2016: 141 · 2015: 138 · 2014: 151 · 2013: 141 · 2012: 164
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- cell cycle checkpoints, DNA damage response, DNA repair, cancer, DNA-damaging agents, radiation, cancer therapy toxicity, carcinogenesis
- MeSH terms
- Animals, Cell Cycle, DNA Damage, Humans, Neoplasms, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review